Yep, efficacy will definitely bring world-wide attention to this humble little stock that right now is quietly hidden away in the world's most remote city, and with it a MC that will be many, many multiples of where it sits currently.
Triple this you say Zac? I would suggest waaay beyond triple if efficacy is shown myself.
As the board of AGN put it, Proving the neuroprotective ability of ARG-007 will be a significant derisking milestone for the Company and opportunity to place Argenica at the forefront of neuroprotective clinical validation.
Yep, efficacy will definitely bring world-wide attention to this...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.0¢ |
Change
-0.010(1.11%) |
Mkt cap ! $110.0M | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 89.0¢ | $158.1K | 174.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3825 | 89.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.0¢ | 5996 | 1 |
View Market Depth
| Last trade - 15.58pm 10/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |